| Genetic and functional drivers of diffuse large B cell lymphoma A Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ... Cell 171 (2), 481-494. e15, 2017 | 1012 | 2017 |
| A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy WWL Choi, DD Weisenburger, TC Greiner, MA Piris, AH Banham, ... Clinical cancer research 15 (17), 5494-5502, 2009 | 851 | 2009 |
| MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression … S Hu, ZY Xu-Monette, A Tzankov, T Green, L Wu, A Balasubramanyam, ... Blood, 2013 | 813 | 2013 |
| The genetic landscape of mutations in Burkitt lymphoma C Love, Z Sun, D Jima, G Li, J Zhang, R Miles, KL Richards, CH Dunphy, ... Nature genetics 44 (12), 1321-1325, 2012 | 681 | 2012 |
| Genetic heterogeneity of diffuse large B-cell lymphoma J Zhang, V Grubor, CL Love, A Banerjee, KL Richards, PA Mieczkowski, ... Proceedings of the National Academy of Sciences 110 (4), 1398-1403, 2013 | 632 | 2013 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 566 | 2013 |
| Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large … C Visco, Y Li, ZY Xu-Monette, RN Miranda, TM Green, A Tzankov, W Wen, ... Leukemia 26 (9), 2103-2113, 2012 | 407 | 2012 |
| Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell–like and non–germinal center B-cell–like subtypes of diffuse large B … K Fu, DD Weisenburger, WWL Choi, KD Perry, LM Smith, X Shi, CP Hans, ... Journal of Clinical Oncology 26 (28), 4587-4594, 2008 | 403 | 2008 |
| Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP … ZY Xu-Monette, L Wu, C Visco, YC Tai, A Tzankov, W Liu, ... Blood, The Journal of the American Society of Hematology 120 (19), 3986-3996, 2012 | 398 | 2012 |
| Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression WWL Choi, MM Lewis, D Lawson, Q Yin-Goen, GG Birdsong, GA Cotsonis, ... Modern pathology 18 (1), 143-152, 2005 | 394 | 2005 |
| Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the … CH Man, TK Fung, C Ho, HHC Han, HCH Chow, ACH Ma, WWL Choi, ... Blood, The Journal of the American Society of Hematology 119 (22), 5133-5143, 2012 | 341 | 2012 |
| CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL … S Hu, ZY Xu-Monette, A Balasubramanyam, GC Manyam, C Visco, ... Blood, The Journal of the American Society of Hematology 121 (14), 2715-2724, 2013 | 282 | 2013 |
| Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs DD Jima, J Zhang, C Jacobs, KL Richards, CH Dunphy, WWL Choi, ... Blood, The Journal of the American Society of Hematology 116 (23), e118-e127, 2010 | 268 | 2010 |
| The genetic basis of hepatosplenic T-cell lymphoma M McKinney, AB Moffitt, P Gaulard, M Travert, L De Leval, A Nicolae, ... Cancer discovery 7 (4), 369-379, 2017 | 202 | 2017 |
| Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International … C Visco, A Tzankov, ZY Xu-Monette, RN Miranda, YC Tai, Y Li, W Liu, ... Haematologica 98 (2), 255, 2013 | 196 | 2013 |
| Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP A Tzankov, ZY Xu-Monette, M Gerhard, C Visco, S Dirnhofer, N Gisin, ... Modern pathology 27 (7), 958-971, 2014 | 171 | 2014 |
| Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries CY Ok, L Li, ZY Xu-Monette, C Visco, A Tzankov, GC Manyam, ... Clinical Cancer Research 20 (9), 2338-2349, 2014 | 159 | 2014 |
| The whole-genome landscape of Burkitt lymphoma subtypes RI Panea, CL Love, JR Shingleton, A Reddy, JA Bailey, AM Moormann, ... Blood, The Journal of the American Society of Hematology 134 (19), 1598-1607, 2019 | 145 | 2019 |
| Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Q Ye, ZY Xu-Monette, A Tzankov, L Deng, X Wang, GC Manyam, C Visco, ... Oncotarget 7 (3), 2401, 2016 | 128 | 2016 |
| Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma YW Chen, T Guo, L Shen, KY Wong, Q Tao, WWL Choi, RKH Au-Yeung, ... Blood, The Journal of the American Society of Hematology 125 (10), 1589-1600, 2015 | 116 | 2015 |
Lynette SmithUniversity of Nebraska Medical Center在 unmc.edu 的电子邮件经过验证
